Form 4 for CYTK CYTOKINETICS INC
Accepted 2021-07-02 00:00:00 ET · period of report 2021-07-01 · accession 0001061983-21-000172 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-02 | 2021-07-01 | CYTK | Kaye Edward M. MD | Dir | A - Grant | $20.98 | +476 | 6,396 | +8% | +$9,986 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-01 | A | A | 476 | $20.98 | 6,396 | D | — | — | (F2) Amount includes 1,396 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. |